EPISODE · Mar 16, 2023 · 6 MIN
Thursday, March 16, 2023
from The Gist Healthcare Podcast
The Biden Administration will fine the drug manufacturers of 27 medicines for sharp price increases. The FDA approves Pfizer’s bivalent COVID booster for children as young as six months. And, the FDA says that Paxlovid is not responsible for rebound infections of COVID-19 ahead of an advisory committee meeting. That’s coming up on today’s episode of Gist Healthcare Daily. Hosted on Acast. See acast.com/privacy for more information.
What this episode covers
The Biden Administration will fine the drug manufacturers of 27 medicines for sharp price increases. The FDA approves Pfizer’s bivalent COVID booster for children as young as six months. And, the FDA says that Paxlovid is not responsible for rebound infections of COVID-19 ahead of an advisory committee meeting. That’s coming up on today’s episode of Gist Healthcare Daily. Hosted on Acast. See acast.com/privacy for more information.
NOW PLAYING
Thursday, March 16, 2023
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m